GUOFUHEE (02582) completed the placement of 4.909 million shares, raising approximately HK$148.5 million net.
Guo Fu Hydrogen Energy (02582) announced that all conditions set out in the placement agreement have been met, and the placement has been completed on March 18, 2026 in accordance with the terms of the placement agreement. The placement agent has placed a total of 4.909 million shares of placement shares to no fewer than six placing agents at a placement price of HK$31.07 per share. The total proceeds from the placement are approximately HK$152.5 million, while the net proceeds are approximately HK$148.5 million. The company plans to use approximately 70% of the net proceeds from the placement for working capital and general corporate purposes to support the business operations and growth of the group, and approximately 30% to repay outstanding amounts under existing credit financing arrangements.
GUOFUHEE (02582) announced that all conditions set out in the placement agreement have been met, and the placement has been completed on March 18, 2026, in accordance with the terms of the placement agreement. The placement agent has placed a total of 4.909 million shares of placement shares to no less than six placees at a placement price of HK$31.07 per share. The total proceeds from the placement amount to approximately HK$152.5 million, with net proceeds of approximately HK$148.5 million. The company intends to use approximately 70% of the net proceeds from the placement for working capital and general corporate purposes to support the business operations and growth of the group, and approximately 30% to repay outstanding amounts under existing credit facilities.
Related Articles

CN ENGY STORAGE (01143): Wang Qi resigns as executive director

Zhejiang Huahai Pharmaceutical (600521.SH): HB0025 Injection Initiates Phase III Clinical Trial for Endometrial Cancer.

Director and General Manager Ge Jianghong of Huada Automotive Technology Corp.,Ltd (603358.SH) plans to increase holdings by 15 million to 30 million yuan.
CN ENGY STORAGE (01143): Wang Qi resigns as executive director

Zhejiang Huahai Pharmaceutical (600521.SH): HB0025 Injection Initiates Phase III Clinical Trial for Endometrial Cancer.

Director and General Manager Ge Jianghong of Huada Automotive Technology Corp.,Ltd (603358.SH) plans to increase holdings by 15 million to 30 million yuan.

RECOMMEND

European Carmakers Embrace China: Under Technology And Cost Pressure, Stellantis And Mercedes Seek Partnerships With Chinese Automakers
17/03/2026

HKEX Listing Mechanism Reform Revisited: How To Balance New Favorites And Established Names
17/03/2026

International Oil Prices Plunge Boosts U.S. Stocks; Morgan Stanley Chief Says Market Correction Nearing End
17/03/2026


